Mesenchymal stem cells neuronal differentiation ability: A real perspective for nervous system repair?

Current Stem Cell Research and Therapy

Volumn 6, Issue 2, 2011, Pages 82-92

  Scuteri, Arianna ^a   Miloso, Mariarosaria ^a   Foudah, Dana ^a   Orciani, Monia ^b   Cavaletti, Guido ^a   Tredici, Giovanni ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Mesenchymal stem cells; Nervous system repair; Neuronal differentiation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BUTYLATED HYDROXYANISOLE; CYTOKINE; DIMETHYL SULFOXIDE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MERCAPTOETHANOL; NEUROGENIN 1; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; NOTCH RECEPTOR; RETINOIC ACID; TRANSCRIPTION FACTOR;

ARTICLE; BONE MARROW; CARCINOGENESIS; CELL DIFFERENTIATION; COCULTURE; GENETIC MANIPULATION; HUMAN; MARKER GENE; MESENCHYMAL STEM CELL; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STEM CELLS; NERVE REGENERATION; NEURONS;

EID: 79955684801     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488811795495486     Document Type: Article

References (110)

1. Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 1997; 276: 71-74.
2. Pittenger MF, MacKay AM, Beck SC, et al. Multilineage potentialof adult human mesenchymal stem cells. Science 1999; 284: 147-43.
3. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria fordefining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;4: 315-317.
4. Krabbe C, Zimmer J, Meyer M. Neural transdifferentiation of mes-enchymal stem cells--a critical review. APMIS 2005; 113: 831-844.
5. Bobis S, Jarocha D, Majka M. Mesenchymal stem cell: characteristics and clinical applications. Folia Histochem Cytobiol 2006; 44:215-230.
6. Zeidán-Chuliá F, Noda M. Opening the mesenchymal stem celltool box. Eur J Dent 2009; 3: 240-249.
7. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Sup-pression of allogeneic T-cell proliferation by human marrow stro-mal cells: implications in transplantation. Transplantation 2003; 75:389-397.
8. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in healthand disease. Nat Rev Immunol 2008; 8: 726-36.
9. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat andhuman bone marrow stromal cells differentiate into neurons. J Neu-rosci Res 2000; 61: 364-70.
10. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bonemarrow stromal cells differentiate into neural cells in vitro. ExpNeurol 2000; 164: 247-56.
11. [Deng W, Obrocka M, Fischer I, Prockop DJ. In vitro differentiationof human marrow stromal cells into early progenitors of neuralcells by conditions that increase intracellular cyclic AMP. BiochemBiophys Res Commun 2001; 282: 148-52.
12. Rismanchi N, Floyd CL, Berman RF, Lyeth BG. Cell death andlong-term maintenance of neuron-like state after differentiation ofrat bone marrow stromal cells: a comparison of protocols. BrainRes 2003; 991: 46-55.
13. Lu P, Blesch A, Tuszynski MH. Induction of bone marrow stromalcells to neurons: differentiation, transdifferentiation, or artifact? JNeurosci Res 2004; 77: 174-91.
14. Neuhuber B, Gallo G, Howard L, Kostura L, Mackay A, Fischer I.Reevaluation of in vitro differentiation protocols for bone marrowstromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J NeurosciRes 2004; 77: 192-204.
15. Bertani N, Malatesta P, Volpi G, Sonego P, Perris R. Neurogenicpotential of human mesenchymal stem cells revisited: analysis byimmunostaining, time-lapse video and microarray. J Cell Sci 2005;118: 3925-36.
16. Choi CB, Cho YK, Prakash KV, et al. Analysis of neuron-likedifferentiation of human bone marrow mesenchymal stem cells.Biochem Biophys Res Commun 2006; 350: 138-46.
17. Wenisch S, Trinkaus K, Hild A, et al. Immunochemical, ultrastructural and electrophysiological investigations of bone-derived stem cells in the course of neuronal differentiation. Bone 2006; 38: 911-21.
18. Barnabé GF, Schwindt TT, Calcagnotto ME, et al. Chemically-induced RAT mesenchymal stem cells adopt molecular properties of neuronal-like cells but do not have basic neuronal functional properties. PLoS One 2009; 4: e5222.
19. Mareschi K, Novara M, Rustichelli D, et al. Neural differentiationof human mesenchymal stem cells: Evidence for expression of neu-ral markers and eag K+ channel types. Exp Hematol 2006; 34:1563-1572.
20. Rooney GE, Howard L, O'Brien T, Windebank AJ, Barry FP. Elevation of cAMP in mesenchymal stem cells transiently upregulates neural markers rather than inducing neural differentiation. Stem Cells Dev 2009; 18: 387-398.
21. Jori FP, Napolitano MA, Melone MA, et al. Molecular pathwaysinvolved in neural in vitro differentiation of marrow stromal stemcells. J Cell Biochem 2005; 94: 645-55.
22. Tondreau T, Dejeneffe M, Meuleman N, et al. Gene expression pattern of functional neuronal cells derived from human bone mar-row mesenchymal stromal cells. BMC Genomics 2008; 9: 166.
23. Kim BJ, Seo JH, Bubien JK, Oh YS. Differentiation of adult bonemarrow stem cells into neuroprogenitor cells in vitro. Neuroreport 2002; 13: 1185-8.
24. Qian L, Saltzman WM. Improving the expansion and neuronal differentiation of mesenchymal stem cells through culture surface modification. Biomaterials 2004; 25: 1331-7.
25. Jin K, Mao XO, Batteur S, Sun Y, Greenberg DA. Induction ofneuronal markers in bone marrow cells: differential effects ofgrowth factors and patterns of intracellular expression. Exp Neurol 2003; 184: 78-89.
26. Carleton A, Petreanu LT, Lansford R, Alvarez-Buylla A, Lledo PM. Becoming a new neuron in the adult olfactory bulb. Nat Neurosci 2003; 6: 507-18.
27. Phinney DG, Prockop DJ. Concise review: mesenchymalstem/multipotent stromal cells: the state of transdifferentiation andmodes of tissue repair-current views. Stem Cells 2007; 25: 2896-902.
28. Cho KJ, Trzaska KA, Greco SJ, et al. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1alpha. Stem Cells 2005; 23: 383-391.
29. Greco SJ, Zhou C, Ye JH, Rameshwar P. An interdisciplinaryapproach and characterization of neuronal cells transdifferentiatedfrom human mesenchymal stem cells. Stem Cells Dev 2007; 16:811-826.
30. Trzaska KA, King CC, Li KY, et al. Brain-derived neurotrophicfactor facilitates maturation of mesenchymal stem cell-derived do-pamine progenitors to functional neurons. J Neurochem 2009; 110:1058-1069.
31. Zhao LX, Zhang J, Cao F, et al. Modification of the brain-derived neurotrophic factor gene: a portal to transform mesenchymal stemcells into advantageous engineering cells for neuroregeneration and neuroprotection. Exp Neurol 2004; 190: 396-406.
32. Dezawa M, Kanno H, Hoshino M, et al. Specific induction of neuronal cells from bone marrow stromal cells and application forautologous transplantation. J Clin Invest 2004; 113: 1701-1710.
33. Gaiano N, Fishell G. The role of notch in promoting glial and neu-ral stem cell fates. Annu Rev Neurosci 2002; 25: 471-90.
34. Hayase M, Kitada M, Wakao S, et al. Committed neural progenitorcells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. J Cereb Blood Flow Metab 2009; 29: 1409-1420.
35. Kim SS, Yoo SW, Park TS, et al. Neural induction with neuro-genin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells 2008; 26: 2217-2228.
36. Ballas N, Grunseich C, Lu DD, Speh JC, Mandel G. REST and itscorepressors mediate plasticity of neuronal gene chromatin through out neurogenesis. Cell 2005; 121: 645-57.
37. Trzaska KA, Reddy BY, Munoz JL, Li KY, Ye JH, Rameshwar P.Loss of RE-1 silencing factor in mesenchymal stem cell-deriveddopamine progenitors induces functional maturity. Mol Cell Neu-rosci 2008; 39: 285-290.
38. Yang Y, Li Y, Lv Y, et al. NRSF silencing induces neuronal differ-entiation of human mesenchymal stem cells. Exp Cell Res 2008;314: 2257-65.
39. Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy forhuman neurodegenerative disorders-how to make it work. Nat Med 2004; 10: S42-50.
40. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992; 255: 1707-1710.
41. Ray J, Peterson DA, Schinstine M, Gage FH. Proliferation, differ-entiation, and long-term culture of primary hippocampal neurons. Proc Natl Acad Sci USA 1993; 90: 3602-3606.
42. Conti L, Pollard SM, Gorba T, et al. Niche-independent symmetri-cal self-renewal of a mammalian tissue stem cell. PLoS Biol 2005;3: e283.
43. Pevny L, Rao MS. The stem-cell menagerie. Trends Neurosci 2003; 26: 351-9.
44. Kabos P, Ehtesham M, Kabosova A, Black KL, Yu JS. Generationof neural progenitor cells from whole adult bone marrow. Exp Neu-rol 2002; 178: 288-93.
45. Kim S, Honmou O, Kato K, et al. Neural differentiation potentialof peripheral blood- and bone-marrow-derived precursor cells. Brain Res 2006; 1123: 27-33.
46. Suzuki H, Taguchi T, Tanaka H, et al. Neurospheres induced frombone marrow stromal cells are multipotent for differentiation intoneuron, astrocyte, and oligodendrocyte phenotypes. Biochem Bio-phys Res Commun 2004; 322: 918 22.
47. Fu L, Zhu L, Huang Y, Lee TD, Forman SJ, Shih CC. Derivation of neural stem cells from mesenchymal stemcells: evidence for abipotential stem cell population. Stem Cells Dev 2008; 17: 1109-21.
48. Hermann A, Gastl R, Liebau S, et al. Efficient generation of neuralstem cell-like cells from adult human bone marrow stromal cells. J Cell Sci 2004; 117: 4411-4422.
49. Hermann A, Liebau S, Gastl R, et al. Comparative analysis ofneuroectodermal differentiation capacity of human bone marrowstromal cells using various conversion protocols. J Neurosci Res 2006; 83: 1502-1514.
50. Wislet-Gendebien S, Leprince P, Moonen G, Rogister B. Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. J Cell Sci 2003; 116: 3295-3302.
51. Kucia M, Zhang YP, Reca R, et al. Cells enriched in markers of neural tissue-committed stem cells reside in the bone marrow andare mobilized into the peripheral blood following stroke. Leukemia 2006; 20: 18-28.
52. Croft AP, Przyborski SA. Mesenchymal stem cells express ingneural antigens instruct a neurogenic cell fate on neural stem cells. Exp Neurol 2009; 216: 329-341.
53. Xu R, Jiang X, Guo Z, et al. Functional analysis of neuron-likecells differentiated from neural stem cells derived from bone mar-row stroma cells in vitro. Cell Mol Neurobiol 2008; 28: 545-558.
54. Krampera M, Marconi S, Pasini A, et al. Induction of neural-likedifferentiation in human mesenchymal stem cells derived frombone marrow, fat, spleen and thymus. Bone 2007; 40: 382-390.
55. Bossolasco P, Cova L, Calzarossa C, et al. Neuro-glial differentia-tion of human bone marrow stem cells in vitro. Exp Neurol 2005;193: 312-325.
56. Wislet-Gendebien S, Hans G, Leprince P, Rigo JM, Moonen G, Rogister B. Plasticity of cultured mesenchymal stem cells: switchfrom nestin-positive to excitable neuron-like phenotype. Stem Cells 2005; 23: 392-402.
57. Moviglia GA, Varela G, Gaeta CA, Brizuela JA, Bastos F, Saslavsky J. Autoreactive T cells induce in vitro BM mesenchymalstem cell transdifferentiation to neural stem cells. Cytotherapy 2006; 8: 196-201.
58. Montzka K, Lassonczyk N, Tschöke B, et al. Neural differentiationpotential of human bone marrow-derived mesenchymal stromalcells: misleading marker gene expression. BMC Neurosci 2009; 10:16.
59. Gangemi RM, Perera M, Corte G. Regulatory genes controlling cellfate choice in embryonic and adult neural stem cells. J Neurochem 2004; 89: 286-306.
60. Guillemot F. Cell fate specification in the mammalian telencepha-lon. Prog Neurobiol 2007; 83: 37-52.
61. Wen S, Li H, Liu J. Epigenetic background of neuronal fate deter-mination. Prog Neurobiol 2009; 87: 98-117.
62. Suh H, Deng W, Gage FH. Signaling in adult neurogenesis. Annu Rev Cell Dev Biol 2009; 25: 253-75.
63. Etheridge SL, Spencer GJ, Heath DJ, Genever PG. Expressionprofiling and functional analysis of wnt signaling mechanisms inmesenchymal stem cells. Stem Cells 2004; 22: 849-60.
64. Ling L, Nurcombe V, Cool SM. Wnt signaling controls the fate of mesenchymal stem cells. Gene 2009; 433: 1-7.
65. Yanjie J, Jiping S, Yan Z, Xiaofeng Z, Boai Z, Yajun L. Effects ofNotch-1 signalling pathway on differentiation of marrow mesen-chymal stem cells into neurons in vitro. Neuroreport 2007; 18:1443-7.
66. Tezuka K, Yasuda M, Watanabe N, et al. Suppression of differen-tiation and proliferation of early chondrogenic cells by Notch. JBone Miner Res 2002; 17: 231-9.
67. Miloso M, Scuteri A, Foudah D, Tredici G. MAPK as mediator of cell fate determination: an approach to neurodegenerative diseases. Curr Med Chem 2008; 15: 538-548.
68. Jin HK, Bae JS, Furuya S, Carter JE. Amyloid beta-derived neuro-plasticity in bone marrow-derived mesenchymal stem cells is medi-ated by NPY and 5-HT2B receptors via ERK1/2 signalling path-ways. Cell Prolif 2009; 42: 571-586.
69. Mruthyunjaya S, Manchanda R, Godbole R, Pujari R, Shiras A, Shastry P. Laminin-1 induces neurite outgrowth in human mesen-chymal stem cells in serum/differentiation factors-free conditions through activation of FAK-MEK/ERK signaling pathways. Bio-chem Biophys Res Commun 2010; 391: 43-8.
70. Salasznyk RM, Klees RF, Hughlock MK, Plopper GE. ERK signal-ing pathways regulate the osteogenic differentiation of human mes-enchymal stem cells on collagen I and vitronectin. Cell Commun Adhes 2004; 11: 137-153.
71. Cárcamo-Orive I, Tejados N, Delgado J, et al. ERK2 protein regulates the proliferation of human mesenchymal stem cells without affecting their mobilization and differentiation potential. Exp Cell Res. 2008; 314: 1777-88.
72. Wu L, Cai X, Dong H, et al. Serum regulates adipogenesis of mes-enchymal stem cells via MEK/ERK dependent PPARgamma ex-pression and phosphorylation. J Cell Mol Med 2010; 14(4): 922-932.
73. Barzilay R, Melamed E, Offen D. Introducing transcription factorsto multipotent mesenchymal stem cells: making transdifferentiationpossible. Stem Cells 2009; 27: 2509-15.
74. Blum B, Benvenisty N. The tumorigenicity of human embryonicstem cells. Adv Cancer Res 2008; 100: 133-58.
75. Choi SC, Kim SJ, Choi JH, Park CY, Shim WJ, Lim DS. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrowmesenchymal stem cells by the activation of the PI3K-Akt andERK1/2 signaling pathways. Stem Cells Dev 2008; 17: 725-736.
76. McMahon JM, Conroy S, Lyons M, et al. Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev 2006; 15: 87-96.
77. Nair V. Retrovirus-induced oncogenesis and safety of retroviral vectors. Curr Opin Mol Ther 2008; 10: 431-8.
78. Zhou H, Wu S, Joo JY, et al. Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins. Cell Stem Cell 2009; 4:381-4.
79. Foudah D, Redaelli S, Bentivegna A, Miloso M, Tredici G. Monitoring the genomic stability of in vitro cultured rat bone marrow-derived mesenchymal stem cells. Chromosome Res 2009; 17:1025-39.
80. Tondreau T, Lagneaux L, Dejeneffe M, et al. Bone marrow-derivedmesenchymal stem cells already express specific neural proteinsbefore any differentiation. Differentiation 2004; 72: 319-26.
81. Mason DJ, Suva LJ, Genever PG, et al. Mechanically regulatedexpression of a neural glutamate transporter in bone: a role for ex-citatory amino acids as osteotropic agents? Bone 1997; 20: 199-205.
82. Egusa H, Schweizer FE, Wang CC, Matsuka Y, Nishimura I. Neu-ronal differentiation of bone marrow-derived stromal stem cells in-volves suppression of discordant phenotypes through gene silenc-ing. J Biol Chem 2005; 280: 23691-7.
83. Maestroni GJ. Neurohormones and catecholamines as functionalcomponents of the bone marrow microenvironment. Ann N Y AcadSci 2000; 917: 29-37.
84. Labouyrie E, Dubus P, Groppi A, et al. Expression of neurotro-phins and their receptors in human bone marrow. Am J Pathol 1999; 154: 405-415.
85. Yamazaki K, Allen TD. Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, andthe recognition of a novel anatomical unit: the neuro-reticularcomplex. Am J Anat 1990; 187: 261-76.
86. Heubach JF, Graf EM, Leutheuser J, et al. Electrophysiological properties of human mesenchymal stem cells. J Physiol 2004; 554:659-72.
87. Reh TA. Neural stem cells: form and function. Nat Neurosci 2002;5: 392-4.
88. Scuteri A, Cassetti A, Tredici G. Adult mesenchymal stem cellsrescue dorsal root ganglia neurons from dying. Brain Res 2006;1116: 75-81.
89. Scuteri A, Donzelli E, Ravasi M, Tredici G. Adult mesenchymalstem cells support cisplatin-treated dorsal root ganglion survival. Neurosci Lett 2008; 445: 68-72.
90. Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG. Human mesenchymal stem cell subpopulations express a variety ofneuro-regulatory molecules and promote neuronal cell survival andneuritogenesis. Exp Neurol 2006; 198: 54-64.
91. Castro RF, Jackson KA, Goodell MA, Robertson CS, Liu H, Shine HD. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 2002; 297: 1299.
92. Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 2002; 174: 11-20.
93. Deng YB, Liu XG, Liu ZG, Liu XL, Liu Y, Zhou GQ. Implantation of BM mesenchymal stem cells into injured spinal cord elicits denovo neurogenesis and functional recovery: evidence from a study in rhesus mokeys. Cytotherapy 2006; 8: 210-4.
94. Chen CJ, Ou YC, Liao SL, et al. Transplantation of bone marrow stromal cells for peripheral nerve repair. Exp Neurol 2007; 204:443-453.
95. Cuevas P, Carceller F, Dujovny M, et al. Peripheral nerve regeneration by bone marrow stromal cells. Neurol Res 2002; 24: 634-8.
96. Hardy SA, Maltman DJ, Przyborski SA. Mesenchymal stem cells as mediators of neural differentiation. Curr Stem Cell Res Ther 2008; 3: 43-52.
97. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ. Human stem/progenitor cells from bone marrow promote neuro-genesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 2005; 102: 18171-6.
98. Phinney DG. Biochemical heterogeneity of mesenchymal stem cellpopulations: clues to their therapeutic efficacy. Cell Cycle 2007; 6:2884-9.
99. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progeni-tors from human bone marrow differentiate in vitro according to ahierarchical model. J Cell Sci 2000; 113: 1161-6.
100. Song SU, Kim CS, Yoon SP, et al. Variations of clonal marrowstem cell lines established from human bone marrow in surface epi-topes, differentiation potential, gene expression, and cytokine se-cretion. Stem Cells Dev 2008; 17: 451-61.
101. Takashima Y, Era T, Nakao K, et al. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007; 129:1377-88.
102. Keilhoff G, Stang F, Goihl A, Wolf G, Fansa H. Transdifferentiated mesenchymal stem cells as alternative therapy in supportingnerve regeneration and myelination. Cell Mol Neurobiol 2006; 26:1235-52.
103. Keilhoff G, Goihl A, Langnäse K, Fansa H, Wolf G. Transdifferen-tiation of mesenchymal stem cells into Schwann cell-like myelinat-ing cells. Eur J Cell Biol 2006; 85: 11-24.
104. Tohill M, Mantovani C, Wiberg M, Terenghi G. Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration. Neurosci Lett 2004; 362: 200-3.
105. Brohlin M, Mahay D, Novikov LN, et al. Characterisation of hu-man mesenchymal stem cells following differentiation into Schwann cell-like cells. Neurosci Res 2009; 64: 41-9.
106. Ohtaki H, Ylostalo JH, Foraker JE, et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl AcadSci USA 2008; 105: 14638-43.
107. Bai L, Lennon DP, Eaton V, et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009; 57: 1192-203.
108. Lanza C, Morando S, Voci A, et al. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. J Neurochem 2009; 110: 1674-84.
109. Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cellsameliorate experimental autoimmune encephalomyelitis inducingT-cell anergy. Blood 2005; 106: 1755-61.
110. Gerdoni E, Gallo B, Casazza S, et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007; 61: 219-227.